CaDo Biotechnology IvS
IVSDissolvedAdvertising protectionCVR 38777815Kajerødvej 15, 3460 BirkerødForskning og eksperimentel udvikling indenfor bioteknologi· NACE 721100Est. 2017 · 9 years old— employees
Loading company…
CaDo Biotechnology IvS is a Danish IVS based in Birkerød, operating in the Forskning og eksperimentel udvikling indenfor bioteknologi sector. Incorporated in 2017, the company reported revenue of 21,1 t kr. in its latest annual filing.
In its most recent annual report (2019), CaDo Biotechnology IvS reported a gross profit of 21,1 t kr.. The figures on this page draw on 2 annual filings covering 2018 to 2019. The bottom line showed a net profit of 19,9 t kr., and the EBITDA margin stood at 100%.
At the end of 2019, equity financed 91% of the balance sheet, and current assets covered short-term debt 10.7 times.